help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bone-Larson, C. L.
Right arrow Articles by Kunkel, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bone-Larson, C. L.
Right arrow Articles by Kunkel, S. L.
(American Journal of Pathology. 2000;157:1177-1186.)
© 2000 American Society for Investigative Pathology

Regular Articles

Novel Protective Effects of Stem Cell Factor in a Murine Model of Acute Septic Peritonitis

Dependence on MCP-1

Cynthia L. Bone-Larson*, Cory M. Hogaboam*, Matthew L. Steinhauser*, Sandra H. P. Oliveira*, Nicholas W. Lukacs*, Robert M. Strieter{dagger} and Steven L. Kunkel*

From the Department of Pathology,*
University of Michigan Medical School, Ann Arbor, Michigan; and the Department of Pulmonary and Critical Care Medicine,{dagger}
University of California, Los Angeles, California

Mast cells participate in the host response during sepsis and have been shown to have a protective effect in a murine model of acute septic peritonitis and multi-organ failure initiated by cecal ligation and puncture (CLP). Stem cell factor (SCF) is a hematopoietic cytokine important in mast cell proliferation and activation. In the present study, we examined the protective effects of a single intraperitoneal injection of SCF given 2 hours before CLP surgery in mice. Four days after the CLP surgery, SCF pretreatment significantly improved mouse survival from 29 to 56% and mast cells were absolutely required for this effect. Immunoneutralization studies revealed that the SCF-stimulated release of monocyte chemoattractant protein-1 (MCP-1) into the septic peritoneal cavity contributed to the protective effect of SCF in this model. One potential cellular source of MCP-1 was the SCF-activated mast cell. In addition, SCF pretreatment significantly augmented circulating levels of SCF and the immunomodulatory cytokine interleukin-10 in septic mice, in part because the SCF pretreatment seemed to promote the release of both mediators from the liver. Additional hepatic effects of SCF treatment included an accelerated expression of hepatic levels of signal transducer and activator of transcription-3 (STAT-3) in CLP mice pretreated with SCF. Taken together, the findings from the present study demonstrate that the intraperitoneal delivery of SCF has a major protective effect in a murine model of CLP.




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
A. K. Diamond, L. M. Sweet, K. H. Oppenheimer, D. F. Bradley, and M. Phillippe
Modulation of Monocyte Chemotactic Protein-1 Expression During Lipopolysaccharide-Induced Preterm Delivery in the Pregnant Mouse
Reproductive Sciences, September 1, 2007; 14(6): 548 - 559.
[Abstract] [PDF]

Home page
 Innate ImmunityHome page
M. Riewald, R. J. Petrovan, A. Donner, and W. Ruf
Activated protein C signals through the thrombin receptor PAR1 in endothelial cells
Innate Immunity, October 1, 2003; 9(5): 317 - 321.
[Abstract] [PDF]

Home page
 IOVSHome page
N. Tuaillon, D. F. Shen, R. B. Berger, B. Lu, B. J. Rollins, and C.-C. Chan
MCP-1 Expression in Endotoxin-Induced Uveitis
Invest. Ophthalmol. Vis. Sci., May 1, 2002; 43(5): 1493 - 1498.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.